Recent News

• 03.11.2025 - Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024
• 03.03.2025 - TD Cowen's 45th Annual Health Care Conference
• 02.25.2025 - H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
• 02.18.2025 - Lyell Immunopharma Announces Participation in Upcoming Investor Conferences
• 01.15.2025 - 43rd Annual J.P. Morgan Healthcare Conference
• 01.09.2025 - Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference

Recent Filings

• 03.11.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.11.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.11.2025 - EX-99.1 EX-99.1
• 03.11.2025 - 8-K Current report
• 02.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors